The Europe prefilled syringe market was valued at US$ 1,992.22 million in 2022 and is expected to reach US$ 4,388.29 million by 2030; it is estimated to record a CAGR of 10.4% from 2022 to 2030.
Growing Adoption of Self-Injecting Parenteral Devices Fuels Europe Prefilled Syringe Market
Self-injecting parenteral devices are gaining popularity due to the ease of use and ability to improve patient outcomes. These devices are designed to allow patients to self-administer medications at home or on the go and do not require assistance from healthcare professionals. These self-injection devices can help patients manage their symptoms more effectively and improve their quality of life. Moreover, self-injecting devices offer several advantages over traditional injection methods, such as the reduced risk of needlestick injuries, improved medication adherence, and reduction in overall healthcare costs. They also provide patients with greater control over their treatment, enabling them to adjust dosages and timing according to their individual needs.
Further, pharmaceutical companies are increasingly investing in the development of self-injecting parenteral devices for prefilled syringes, and healthcare providers are encouraging their use as a part of a broader shift toward patient-centered care. With the ongoing advancements in technology and design, self-injecting devices will likely continue to gain popularity in the coming years.
Europe Prefilled Syringe Market Overview
The Europe prefilled syringes market is segmented into Germany, UK, France, Italy, Spain, and the Rest of Europe. The region is expected to hold the second largest position in terms of revenue and market share, driven by the rising prevalence of chronic disorders such as cardiovascular disorders, diabetes, cancer, and fertility issues and increased use of biosimilars available in prefilled syringes. Additionally, the growing trend of home healthcare and self-administration of drugs are expected to propel the prefilled syringes market growth. Furthermore, the increase in R&D activities, innovations, and new product launches will contribute to the prefilled syringes market expansion during 2022-2030.
Europe Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)
Europe Prefilled Syringe Market Segmentation
The Europe prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.
Based on type, the Europe prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Europe prefilled syringe market share in 2022.
Based on material, the Europe prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Europe prefilled syringe share in 2022.
Based on designs, the Europe prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Europe prefilled syringe share in 2022.
In terms of application, the Europe prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Europe prefilled syringe share in 2022.
By distribution channel, the Europe prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Europe prefilled syringe market share in 2022.
Based on country, the Europe prefilled syringe market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe prefilled syringe market in 2022.
B Braun SE, Baxter International Inc, Becton Dickinson and Co, Delta Med SPA, Gerresheimer AG, Nipro Corp, Schott AG, Shandong Weigao Group Medical Polymer Co Ltd, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Europe prefilled syringe market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,992.22 Million |
| Market Size by 2030 | US$ 4,388.29 Million |
| CAGR (2022 - 2030) | 10.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
1. B Braun SE
2. Baxter International Inc
3. Becton Dickinson and Co
4. Delta Med SPA
5. Gerresheimer AG
6. Nipro Corp
7. Schott AG
8. Shandong Weigao Group Medical Polymer Co Ltd
9. Terumo Corp
10. Ypsomed Holding AG
The Europe Prefilled Syringe Market is valued at US$ 1,992.22 Million in 2022, it is projected to reach US$ 4,388.29 Million by 2030.
As per our report Europe Prefilled Syringe Market, the market size is valued at US$ 1,992.22 Million in 2022, projecting it to reach US$ 4,388.29 Million by 2030. This translates to a CAGR of approximately 10.4% during the forecast period.
The Europe Prefilled Syringe Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Prefilled Syringe Market report:
The Europe Prefilled Syringe Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Prefilled Syringe Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Prefilled Syringe Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Prefilled Syringe Market
